Neogen Chemicals Management
Management criteria checks 3/4
Neogen Chemicals' CEO is Harin Kanani, appointed in Oct 2025, has a tenure of 12.25 years. total yearly compensation is ₹15.00M, comprised of 90.7% salary and 9.3% bonuses, including company stock and options. directly owns 11.77% of the company’s shares, worth ₹4.88B. The average tenure of the management team and the board of directors is 1.5 years and 7.7 years respectively.
Key information
Harin Kanani
Chief executive officer
₹15.0m
Total compensation
| CEO salary percentage | 90.67% |
| CEO tenure | no data |
| CEO ownership | 11.8% |
| Management average tenure | 1.5yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
Merger With BuLi Chemicals Will Strengthen Market Position In Pharma And Agrochemicals
The merger and strategic product expansions aim to strengthen Neogen's market position and boost future export and domestic revenue growth.Neogen Chemicals Limited's (NSE:NEOGEN) P/S Is On The Mark
Feb 21
Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 06Here's Why Neogen Chemicals (NSE:NEOGEN) Has A Meaningful Debt Burden
Dec 26The Returns On Capital At Neogen Chemicals (NSE:NEOGEN) Don't Inspire Confidence
Dec 10Why Neogen Chemicals' (NSE:NEOGEN) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 20Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
Nov 16Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%
Sep 20We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
May 08Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
May 05After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Apr 26Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Apr 12Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75
Aug 11Neogen Chemicals Limited (NSE:NEOGEN) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10Here's Why I Think Neogen Chemicals (NSE:NEOGEN) Is An Interesting Stock
Feb 09Neogen Chemicals' (NSE:NEOGEN) Returns On Capital Not Reflecting Well On The Business
Sep 21Neogen Chemicals' (NSE:NEOGEN) Dividend Will Be Increased To ₹2.25
Sep 05Neogen Chemicals (NSE:NEOGEN) Will Pay A Larger Dividend Than Last Year At ₹2.25
Aug 11Does Neogen Chemicals (NSE:NEOGEN) Deserve A Spot On Your Watchlist?
Jun 04Should You Think About Buying Neogen Chemicals Limited (NSE:NEOGEN) Now?
May 24Neogen Chemicals (NSE:NEOGEN) May Have Issues Allocating Its Capital
Apr 05Is Neogen Chemicals Limited's(NSE:NEOGEN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 07Should You Buy Neogen Chemicals Limited (NSE:NEOGEN) For Its Dividend?
Feb 21
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | ₹336m |
| Mar 31 2025 | ₹15m | ₹14m | ₹348m |
| Dec 31 2024 | n/a | n/a | ₹494m |
| Sep 30 2024 | n/a | n/a | ₹404m |
| Jun 30 2024 | n/a | n/a | ₹374m |
| Mar 31 2024 | ₹20m | ₹13m | ₹357m |
| Dec 31 2023 | n/a | n/a | ₹330m |
| Sep 30 2023 | n/a | n/a | ₹467m |
| Jun 30 2023 | n/a | n/a | ₹486m |
| Mar 31 2023 | ₹8m | ₹8m | ₹500m |
| Dec 31 2022 | n/a | n/a | ₹513m |
| Sep 30 2022 | n/a | n/a | ₹471m |
| Jun 30 2022 | n/a | n/a | ₹484m |
| Mar 31 2022 | ₹6m | ₹6m | ₹446m |
| Dec 31 2021 | n/a | n/a | ₹383m |
| Sep 30 2021 | n/a | n/a | ₹364m |
| Jun 30 2021 | n/a | n/a | ₹326m |
| Mar 31 2021 | ₹5m | ₹5m | ₹313m |
| Dec 31 2020 | n/a | n/a | ₹293m |
| Sep 30 2020 | n/a | n/a | ₹290m |
| Jun 30 2020 | n/a | n/a | ₹293m |
| Mar 31 2020 | ₹5m | ₹5m | ₹287m |
| Dec 31 2019 | n/a | n/a | ₹301m |
| Sep 30 2019 | n/a | n/a | ₹262m |
| Jun 30 2019 | n/a | n/a | ₹225m |
| Mar 31 2019 | ₹4m | ₹4m | ₹209m |
Compensation vs Market: Harin's total compensation ($USD170.33K) is below average for companies of similar size in the Indian market ($USD296.79K).
Compensation vs Earnings: Harin's compensation has been consistent with company performance over the past year.
CEO
Harin Kanani (49 yo)
Dr. Harin Haridas Kanani, Ph D serves as the Managing Director of Neogen Chemicals Limited since July 22, 2017 and serves as its Executive Director since July 15, 2013. Dr. Kanani served as Joint Managing...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | no data | ₹15.00m | 11.77% ₹ 4.9b | |
| Director of Operations & Whole Time Director | no data | ₹12.50m | 0.00028% ₹ 116.0k | |
| Chief Financial Officer | 1yr | no data | no data | |
| Company Secretary & Compliance Officer | 5.9yrs | ₹690.56k | no data | |
| Senior General Manager of Marketing | no data | no data | no data | |
| Senior Vice President of Human Resource | no data | no data | no data | |
| Senior Vice President of Business Development | 2yrs | no data | no data |
Experienced Management: NEOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 12.3yrs | ₹15.00m | 11.77% ₹ 4.9b | |
| Director of Operations & Whole Time Director | 10.3yrs | ₹12.50m | 0.00028% ₹ 116.0k | |
| Non-Executive Non-Independent Chairman | 8.4yrs | no data | 0.79% ₹ 328.5m | |
| Chairman Emeritus | 36.6yrs | ₹15.00m | 35.84% ₹ 14.8b | |
| Independent Non-Executive Director | 7yrs | ₹400.00k | no data | |
| Independent Non-Executive Woman Director | 7yrs | ₹500.00k | no data | |
| Independent Director | 1.2yrs | ₹200.00k | 0.0011% ₹ 439.2k | |
| Independent Director | 1yr | ₹200.00k | no data |
Experienced Board: NEOGEN's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/18 10:55 |
| End of Day Share Price | 2025/10/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Neogen Chemicals Limited is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Nav Bhardwaj | Anand Rathi Shares and Stock Brokers Limited |
| Bhawana Israni | Anand Rathi Shares and Stock Brokers Limited |